Rafael Martín Lab
Laboratory led by Rafael Martín within the Bionanosurf research group.
Lab summary
Rafael Martín’s research focuses on polymer materials for biomedical applications, with an emphasis on tuning chemical and physical properties through molecular design and chemical synthesis.
His work spans interdisciplinary research lines including polymeric drug delivery systems, hybrid antimicrobial materials, and polymeric scaffolds for tissue engineering.
Team
Anabela Carnicero
Paula Novella Rodríguez
Pre doc
Mariella Malefíoudaki
Pre doc
Natalia Esteban
Pre doc
Carlos Rodríguez
Tamara Bolaño Garcia
Profesora Ayudante Doctora
Lab quick facts
- ORCID: 0000-0003-0702-8260
Selected projects
- Bioactive organic-inorganic polyoxometalate hybrids to tackle the emerging threat of antifungal resistance (QIQOMIC) Proyectos de Generación de Conocimiento 2022. PIs: Scott G. Mitchell and Rafael Martín. 2023-2026.
- Combatiendo el biodeterioro de pinturas de óleo sobre lienzo utilizando nanomateriales antimicrobianos adhesivos (COMBINA) Gobierno de Aragón, Proyectos de I+D+i en líneas prioritarias y de carácter multidisciplinar 2024-2026. PI: Scott G. Mitchell; Rafael Martín participates in the research team. 2025-2026.
- Stimuli-responsive organic-inorganic hybrids to tackle the emerging threat of antimicrobial resistance (POM-deter) Complementary R&D&I Plan for Advanced Materials for Technological Transformation. PIs: Inés García and Rafael Martín. 2024-2025.
Latest publications
-
Förster Resonance Energy Transfer (FRET) Demonstrates In Vitro Chitosan-Coated Nanocapsules Suitability for Intranasal Brain DeliveryACS Applied Materials & Interfaces · May 7, 2025
-
Multifunctional polyoxomolybdate ionic liquid coatings for mitigating microbiologically influenced corrosionMaterials Horizons · January 1, 2025
-
Evaluation of gelatin-based hydrogels for colon and pancreas studies using 3D <i>in vitro</i> cell cultureJournal of Materials Chemistry B · January 1, 2024
-
Acid- and base-resistant antimicrobial hydrogels based on polyoxometalates and chitosanRSC Pharmaceutics · January 1, 2024